Back to mobile site

More on BMEA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.3 Score)

Upcoming Events

- Earnings (8/3/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Biomea Fusion, Inc. (NQ:BMEA)
Delayed: 1.36 -0.11 (7.48%)
Prev. Close $1.47  
Open$1.48 
52 Wk High$ 
52 Wk Low$ 
Day High$1.49 
Day Low$1.32 
P/E N/A  
EPS$ 
Volume1,380,390 


Jun 23, 2026 04:34 PM Oppenheimer Assumes Biomea Fusion Inc. (BMEA) at Outperform
Jun 12, 2026 04:16 PM Form 4 Biomea Fusion, Inc. For: Jun 10 Filed by: Ray Sumita
Jun 12, 2026 04:16 PM Form 4 Biomea Fusion, Inc. For: Jun 10 Filed by: AGUIAR ERIC
Jun 12, 2026 04:16 PM Form 4 Biomea Fusion, Inc. For: Jun 10 Filed by: Faust Elizabeth
Jun 12, 2026 04:15 PM Form 4 Biomea Fusion, Inc. For: Jun 10 Filed by: Averill Julianne
Jun 11, 2026 07:12 AM Form 8-K Biomea Fusion, Inc. For: Jun 10
Jun 5, 2026 07:32 PM Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 S
Jun 3, 2026 08:03 AM Biomea Fusion partners with University of Leicester for obesity study
Jun 3, 2026 08:00 AM Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity
May 12, 2026 04:05 PM Biomea Fusion to Participate at Upcoming Investor Conferences
View All Articles

Entities mentioned with BMEA

View All Entities